Medical response in East Ghouta reaches its limits
MSF calls for an immediate ceasefire to enable the basic human act of helping the sick and wounded.
Central African Republic
Outbursts of violence deprive civilians of access to medical care
Outside the capital Bangui, Central African Republic has grown increasingly unstable over the past months. MSF is a direct witness to the impact this conflict is having on the country's already fragile healthcare system.
How about making a bequest?
Médecins Sans Frontières Luxembourg launches a campaign to raise awareness about bequests.This powerful topic is addressed with sensitivity in TV and radio spots that will begin airing on 25 December.
At least 6,700 Rohingya were killed during the attacks in Myanmar
Surveys conducted by MSF estimate that at least 9,000 Rohingya died in Myanmar, of which 71.7% were caused by violence.
Rohingya refugees in Bangladesh: a community on the brink of disaster
"If the situation does not improve rapidly, the public health emergency we are facing will escalate dramatically."
Emergencies can't wait! Your donation saves lives
MSF Luxembourg is launching a new awareness-raising campaign and call for donations, in the cinema, press, and on the internet, carrying the message: emergencies can't wait!
The European Union accomplices in a criminal detention system in Libya
The European migration policy is being pursued inexorably, regardless of the devastating consequences on the lives and health of thousands of refugees and migrants now trapped in Libya, where they face horrible suffering.
Urgent need for improved water and sanitation to curb cholera
An urgent scale-up of aid is needed in the northern district of Abs, the area worst affected by the outbreak.
Review of the year, 2016
71 countries, 468 humanitarian projects, 9,8 million out-patient medical consultations and hospitalised over 670,000 patients.
MSF joins Europe-wide action challenging patent on key hepatitis C drug
Patent opposition aims to increase affordable access to hepatitis C drug sofosbuvir for millions.